225 Results
Tabulating NIAID’s R01 and R21 Application and Award Counts for FY 2024
Funding News Edition: December 18, 2024
Each year, we share the number of R01-equivalent and R21 applications that NIAID received in the previous fiscal year as well as the number of grants NIAID awarded.
News Briefs and Worth Repeating
Funding News Edition: December 18, 2024
Increased Interim Paylines for Fellowship, Career Development Awards; NIH Develops Training Resources for Responsible Conduct of Research; Enhance Your Presentations with High-Quality Science and Biomedical Art Illustrations
Unobligated Funds, Renewals, and Carryovers—Oh My!
Funding News Edition: December 18, 2024
Submitting complete and timely Federal Financial Reports is an important step to ensure NIAID’s prompt review and consideration of any carryover requests.
“Does the Big Grants policy check for an application’s average annual direct costs or any single year above the threshold?”
Funding News Edition: December 18, 2024
Any unsolicited application with a budget of $500,000 or more in direct costs in any year requires that you submit documentation with your application stating you have discussed it with an NIH program officer and the institute has agreed to accept it.
“If I include an illustration in my application, does it count against my page limit?”
Funding News Edition: December 18, 2024
Yes, an image included in your grant application’s Research Strategy would count against the page limit.
Help Develop Long-Acting and Simplified HIV Treatments
Funding News Edition: December 18, 2024
NIAID will support the development of safe and effective long-acting/sustained release technologies to help prevent and treat HIV and related co-infections such as tuberculosis, hepatitis B, and hepatitis C.
Contribute to Development of a Universal Influenza Vaccine
Funding News Edition: December 18, 2024
NIAID aims to foster new and innovative scientific endeavors related to universal influenza vaccine research that advance the major research areas defined in our Strategic Plan for the Development of a Universal Influenza Vaccine.
Leverage Microbial Exposure to Improve Mouse Models of Human Immunity
Funding News Edition: December 18, 2024
Advance our understanding of the impact of a host’s microbial experience on the development and function of host immunity and provide the data necessary to encourage broader use of the mouse models in immunologic and microbiologic research.
December ACD Meeting—Defining Strategies for Major Initiatives Across NIH
Funding News Edition: December 18, 2024
NIH’s Advisory Committee to the Director (ACD) provides recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.
New NOSI Prioritizes Malaria Vaccine and Monoclonal Antibody Discovery
Funding News Edition: December 18, 2024
Help ensure future effective global malaria control and elimination by focusing on “combination” vaccine concepts to improve efficacy, targeting one or more parasite antigens of the different life cycle stages of the parasites.
Don’t Waste Your Time: Take an Extra Minute When Selecting NOFOs, Form Sets
Funding News Edition: December 4, 2024
We’ve now reached a stretch of time in which two form sets (i.e., FORMS-H and FORMS-I) and two versions of certain notices of funding opportunities (NOFOs) will be active simultaneously.
Establishing Preclinical Animal Models to Study Post-TB Lung Disease Development
Funding News Edition: December 4, 2024
While most of our understanding of Post-TB Lung Disease (PTLD) comes from long-term human cohorts, using animal models for PTLD development could help address difficult mechanistic questions when relying solely on human studies.
Collaborate to Defeat Antibiotic-Resistant Bacterial Infections
Funding News Edition: December 4, 2024
NIAID will support multidisciplinary, collaborative research programs focused on discovery to early development research to inform new approaches to prevent, diagnose, and treat antibiotic-resistant bacterial infections.
Explore Mechanisms of Adverse Health Effects on the Nervous System After Toxic Chemical Exposure
Funding News Edition: December 4, 2024
Propose research on the fundamental mechanisms of toxicity of highly toxic Chemicals of Concern but also on potential new targets to inform the development of medical countermeasures that would be effective during and after civilian mass exposure situations.
Webinar Describes Changes Coming to Fellowship Application and Review
Funding News Edition: December 4, 2024
The newly structured candidate section will ask for four personal statements: 1) a statement of professional and fellowship goals, 2) a statement of fellowship qualifications, 3) a self-assessment, and 4) a statement of scientific perspective.
Create an ORCID Account in Preparation for the May 2025 Common Forms for Biosketch Transition
Funding News Edition: December 4, 2024
Investigators will soon be required to use Science Experts Network Curriculum Vitae (SciENcv) to complete Common Forms and the NIH Biographical Sketch Supplement to produce digitally certified PDFs for their application submission.
News Briefs and Worth Repeating
Funding News Edition: December 4, 2024
HHS Policy Also Caps Indirect Salaries Paid Using Award Funds; Small Business Recipients—Get Help to Hone Your Product Pitch; Read Summary of Recent Artificial Intelligence Use Cases at NIH
How to Determine Where Your Application Will Be Reviewed
Funding News Edition: December 4, 2024
If you know your application will go to a Center for Scientific Review study section, you can request assignment to the most appropriate one.
“Can my program officer help to resolve a dispute with my grant’s subrecipient?”
Funding News Edition: December 4, 2024
You as the grant recipient are responsible for ensuring subrecipients’ research, spending, and progress reporting conform to the terms and conditions of the award.
“One of my key personnel listed several preprints in their biosketch. Is that acceptable?”
Funding News Edition: December 4, 2024
Yes, researchers may list preprints as a type of interim research product within the Personal Statement or Contributions to Science section of the biosketch.
How to Use the World’s Largest Public Clinical Trials Registry as a Resource
Funding News Edition: November 20, 2024
While many researchers treat ClinicalTrials.gov only as a repository to submit required study information, it’s also worth thinking of it as an extensive online library.
Combat Antibiotic Resistance Through Phage Therapy Research
Funding News Edition: November 20, 2024
Propose a multidisciplinary research group that will implement phage therapeutic research by focusing on preclinical development and study pharmacokinetics and pharmacodynamics.
Investigate Understudied Proteins Associated with Rare Diseases
Funding News Edition: November 20, 2024
Gather preliminary data around the role of understudied proteins associated with rare diseases and characterize new targets for treatment of human disease among them.
Conduct Translational Exploratory Research on Chemical Countermeasures
Funding News Edition: November 20, 2024
Research civilian chemical medical countermeasures and novel treatment strategies to combat serious morbidity and mortality resulting from high consequence public health chemical emergencies.
Replication as a Pathway to Reproducibility in Research
Funding News Edition: November 20, 2024
A new initiative will support efforts to independently replicate significant lines of research and validate novel technologies across different scientific research areas in preclinical, translational, and technology development studies.
Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.